PortfoliosLab logoPortfoliosLab logo
ISIN
US16359R1032
CUSIP
16359R103
IPO Date
May 3, 1973

Highlights

Market Cap
$6.49B
Enterprise Value
$6.75B
EPS (TTM)
$18.47
PE Ratio
26.46
PEG Ratio
12.46
Total Revenue (TTM)
$2.54B
Gross Profit (TTM)
$571.36M
EBITDA (TTM)
$396.47M
Year Range
$365.21 - $493.47
Target Price
$475.00
ROA (TTM)
16.91%
ROE (TTM)
30.64%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

CHE Performance Chart

Chemed Corporation (CHE) is up 14.5% since the beginning of the year. At $489 per share, CHE is trading just below its 52-week high of $493. Investors who bought $1,000 worth of CHE shares 5 years ago would now be looking at an investment worth $1,045.


Loading charts...

S&P 500 Index

Returns By Period

Chemed Corporation (CHE) has returned 14.49% so far this year and 6.81% over the past 12 months. Over the last decade, CHE has posted an annualized return of 13.78%, slightly higher than the S&P 500 Index benchmark’s 13.41%.


Chemed Corporation

1D
-0.38%
1M
16.52%
6M
10.23%
YTD
14.49%
1Y
6.81%
3Y*
-2.36%
5Y*
0.88%
10Y*
13.78%

Benchmark (S&P 500 Index)

1D
0.42%
1M
1.94%
6M
8.74%
YTD
10.66%
1Y
21.02%
3Y*
19.50%
5Y*
11.63%
10Y*
13.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CHE Monthly Returns History

Based on dividend-adjusted daily data since May 3, 1973, CHE's average daily return is +0.05%, while the average monthly return is +1.20%. At this rate, an investment would double in approximately 4.8 years.

Historically, 54% of months were positive and 46% were negative. The best month was Oct 1974 with a return of +66.7%, while the worst month was Sep 1974 at -53.9%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.

On a daily basis, CHE closed higher 44% of trading days. The best single day was Dec 19, 2003 with a return of +26.2%, while the worst single day was Sep 30, 1974 at -25.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.17%-3.89%-7.87%12.51%0.47%9.22%4.91%14.49%
20256.08%7.00%2.42%-5.49%-1.06%-15.29%-15.33%11.23%-2.23%-3.67%1.97%-2.58%-18.87%
20241.37%5.70%2.52%-11.52%-2.33%-2.13%5.08%2.90%2.52%-10.11%6.05%-7.44%-9.11%
2023-1.04%3.33%3.10%2.51%-3.10%1.48%-3.80%-1.78%1.62%8.26%0.84%3.13%14.90%
2022-11.37%2.08%5.91%-2.99%-1.35%-3.10%2.49%-0.94%-8.32%6.94%11.47%-1.84%-3.22%
2021-2.76%-13.97%3.28%3.65%3.16%-3.43%0.32%0.22%-2.43%3.68%-3.41%13.65%-0.38%

Benchmark Metrics

Chemed Corporation has an annualized alpha of 8.30%, beta of 0.61, and R2 of 0.13 versus S&P 500 Index. Calculated based on daily prices since May 03, 1973.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (86.35%) than losses (78.76%) - typical of diversified or defensive assets.
  • Beta of 0.61 may look defensive, but with R2 of 0.13 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.13 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
8.30%
Beta
0.61
0.13
Upside Capture
86.35%
Downside Capture
78.76%

Return for Risk

Risk / Return Rank

CHE ranks 50 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


CHE Risk / Return Rank: 5050
Overall Rank
CHE Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
CHE Sortino Ratio Rank: 4646
Sortino Ratio Rank
CHE Omega Ratio Rank: 4747
Omega Ratio Rank
CHE Calmar Ratio Rank: 5252
Calmar Ratio Rank
CHE Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Chemed Corporation (CHE) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CHEBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.48

Sortino ratioReturn per unit of downside risk

-1.85

Omega ratioGain probability vs. loss probability

1.07

1.30

-0.23

Calmar ratioReturn relative to maximum drawdown

0.24

2.28

-2.04

Martin ratioReturn relative to average drawdown

0.56

9.88

-9.33

Dividends

Dividend History

Chemed Corporation provided a 0.49% dividend yield over the last twelve months, with an annual payout of $2.40 per share. The company has been increasing its dividends for 25 consecutive years, earning it the status of a dividend aristocrat.


0.30%0.40%0.50%0.60%$0.00$0.50$1.00$1.50$2.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$2.40$2.20$1.80$1.56$1.48$1.40$1.32$1.24$1.16$1.08$1.00$0.92

Dividend yield

0.49%0.51%0.34%0.27%0.29%0.26%0.25%0.28%0.41%0.44%0.62%0.61%

Monthly Dividends

The table displays the monthly dividend distributions for Chemed Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.60$0.00$0.00$0.60$0.00$0.00$1.20
2025$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.60$0.00$0.00$0.60$0.00$2.20
2024$0.00$0.40$0.00$0.00$0.40$0.00$0.00$0.50$0.00$0.00$0.50$0.00$1.80
2023$0.00$0.38$0.00$0.00$0.38$0.00$0.00$0.40$0.00$0.00$0.40$0.00$1.56
2022$0.00$0.36$0.00$0.00$0.36$0.00$0.00$0.38$0.00$0.00$0.38$0.00$1.48
2021$0.00$0.34$0.00$0.00$0.34$0.00$0.00$0.36$0.00$0.00$0.36$0.00$1.40

Dividend Yield & Payout


Dividend Yield

Chemed Corporation has a dividend yield of 0.49%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Chemed Corporation has a payout ratio of 12.53%, which is below the market average. This means Chemed Corporation returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Chemed Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Chemed Corporation was 83.78%, occurring on Sep 30, 1974. Recovery took 1206 trading sessions.

The current Chemed Corporation drawdown is 24.18%.


Related event

Drawdown

Fall

Recovery

Underwater

1974 bear market1974
-83.78%Sep 1974
1y 4mo4y 9mo
6y 2moMay 1973 - Jul 1979
Financial crisis2007–2009
-54.28%Oct 2008
1y 3mo2y 6mo
3y 9moJul 2007 - Apr 2011
1991 bear market1991
-52.22%Jan 1991
3y 4mo2y 5mo
5y 10moAug 1987 - Jun 1993
2006 bear market2006
-50.93%Oct 2006
5mo 15d7mo 6d
1y 16dApr 2006 - May 2007
2026 bear market2026
-42.88%Mar 2026
2y 7d
2y 3moMar 2024 - now

Drawdown Indicators


CHEBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-83.78%

-56.78%

-27.00%

Max Drawdown (1Y)

Largest decline over 1 year

-22.98%

-9.10%

-13.88%

Max Drawdown (3Y)

Largest decline over 3 years

-42.88%

-18.90%

-23.98%

Max Drawdown (5Y)

Largest decline over 5 years

-42.88%

-25.43%

-17.45%

Max Drawdown (10Y)

Largest decline over 10 years

-42.88%

-33.92%

-8.96%

Current Drawdown

Current decline from peak

-24.18%

-0.45%

-23.73%

Average Drawdown

Average peak-to-trough decline

-16.47%

-10.71%

-5.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.85%

2.09%

+7.76%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Chemed Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Chemed Corporation is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for CHE, comparing it with other companies in the Medical Care Facilities industry. Currently, CHE has a P/E ratio of 26.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for CHE compared to other companies in the Medical Care Facilities industry. CHE currently has a PEG ratio of 12.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CHE relative to other companies in the Medical Care Facilities industry. Currently, CHE has a P/S ratio of 2.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CHE in comparison with other companies in the Medical Care Facilities industry. Currently, CHE has a P/B value of 7.9. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CHE

Add Chemed Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CHE